On Nov. 5, 2021, the USDA’s (USDA) National Veterinary Services Laboratories announced confirmation of SARS-CoV-2 in two spotted…
On Nov. 4, 2021, Novavax announced the completion of its rolling submission to the World Health Organization (WHO)…
On Nov. 3, 2021, Novavax announced the company had filed for provisional approval of the vaccine to the…
On Nov. 5, 2021, Resverlogix announced that it had entered into a cooperation agreement with the Supreme Council…
On Nov. 3, 2021, Innovation Pharma announced that the Company had received confirmation that hard lock of the…
On Nov. 3, 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXINﾮ (developed…
On Nov. 3, 2021, Inovio Pharma announced that it had received authorization from India’s Central Drugs Standard Control…
On Nov. 2, 2021, the National Institutes of Health announced support for a four-year follow-up study on the…
On Nov. 2, 2021, OraSure Technologies announced that the EUA for its InteliSwabﾙ COVID-19 rapid tests had been…
On Nov. 5, 2021, NRx Pharmaceuticals reported a safety update on ZYESAMIﾮ (aviptadil), which was being tested in…
On Nov. 1, 2021, for the first time in the U.S., the transmission of COVID-19 from pet parent…
On Nov. 1, 2021, Novavax announced the completion of its rolling submission to Health Canada for authorization of…
On Nov. 1, 2021, Novavax and Serum Institute of India announced that the National Agency of Drug and…
On Nov. 1, 2021, the U.S. Food and Drug Administration (FDA) cleared the first 510(k) for a COVID-19…
On Oct. 31, 2021, Moderna announced that the U.S. Food and Drug Administration (FDA) had notified the Company…
On Oct. 30, 2021, Penn Medicine officially opened the doors of its 1.5 million-square-foot future-ready Pavilion as clinical…
Our Life-Saving Vaccines cartoon illustrates four invaluable vaccines that have affected human civilization throughout history from smallpox and…
On Oct. 29, 2021, Oregon Health & Science University’s (OHSU) board of directors approved a project to expand…
On Oct. 29, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had authorized…
On Oct. 29, 2021, the Centers for Disease Control and Prevention (CDC) published “new science” reinforcing that vaccination…
On Oct. 29, 2021, research led by scientists at the National Institutes of Health announced they had identified…
On Oct. 29, 2021, Novavax announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA)…
On Oct. 28, 2021, Pfizer and BioNTech announced that the U.S. government had purchased 50 million more doses…
On Oct. 27, 2021, researchers published interim results in The New England Journal of Medicine from a Phase…
On Oct. 27, 2021, the Medicines Patent Pool (MPP) and Merck announced a voluntary licensing agreement to facilitate…
On Oct. 27, 2021, Novavax announced the completion of its rolling regulatory submission to the U.K. Medicines and…
On Oct. 27, 2021, Hologic announced that its Aptima SARS-CoV-2/Flu Assay was available for the simultaneous detection and…
On Oct. 27, 2021, RELIEF THERAPEUTICS announced that its wholly owned subsidiary, APR Applied Pharma Research, reported positive…
On Oct. 27, 2021, Fulgent Genetics announced that it had launched an antibody test for COVID-19 which specifically…
On Oct. 26, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administrationﾒs (FDA) Vaccines and…